Although TRIM69 transcription has not yet been reported to play a role in cancer, the presence of recurrent TRIM69 amplification involving escape from mitotic catastrophe-induced death in Kras cancer strongly suggests that TRIM69 has pro-tumorigenic capacity. This evidence concerns the gene TRIM69 and cancer.